Cryptic intronic NBAS variant reveals the genetic basis of recurrent liver failure in a child.

[1]  Regina M. Hardison,et al.  Liver Transplant Listing in Pediatric Acute Liver Failure: Practices and Participant Characteristics , 2018, Hepatology.

[2]  Marcel E Dinger,et al.  Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy. , 2018, Journal of the American College of Cardiology.

[3]  Abramowicz Anna,et al.  Splicing mutations in human genetic disorders: examples, detection, and confirmation , 2018, Journal of Applied Genetics.

[4]  T. Illig,et al.  Diagnosis of monogenic liver diseases in childhood by next‐generation sequencing , 2018, Clinical genetics.

[5]  L. D’Antiga,et al.  Next generation sequencing in pediatric hepatology and liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  Marcel E. Dinger,et al.  Seave: a comprehensive web platform for storing and interrogating human genomic variation , 2018, bioRxiv.

[7]  Zhongji Pu,et al.  Targeted next-generation sequencing reveals two novel mutations of NBAS in a patient with infantile liver failure syndrome-2 , 2017, Molecular medicine reports.

[8]  F. Tandoi,et al.  NBAS mutations cause acute liver failure: when acetaminophen is not a culprit , 2017, Italian Journal of Pediatrics.

[9]  Zhong Ren,et al.  Annotating pathogenic non-coding variants in genic regions , 2017, Nature Communications.

[10]  J. Casanova,et al.  Recurrent elevated liver transaminases and acute liver failure in two siblings with novel bi-allelic mutations of NBAS. , 2017, European journal of medical genetics.

[11]  Yi Lu,et al.  Novel NBAS mutations and fever-related recurrent acute liver failure in Chinese children: a retrospective study , 2017, BMC Gastroenterology.

[12]  M. Carmo-Fonseca,et al.  Deep intronic mutations and human disease , 2017, Human Genetics.

[13]  Clara Gaff,et al.  Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.

[14]  Winston A Hide,et al.  Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfecta. , 2017, Bone.

[15]  Stephanie Spranger,et al.  Acute Liver Failure Meets SOPH Syndrome: A Case Report on an Intermediate Phenotype , 2017, Pediatrics.

[16]  Jeffrey M. Weiss,et al.  MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder. , 2016, American journal of human genetics.

[17]  Clara Gaff,et al.  Patient safety in genomic medicine: an exploratory study , 2016, Genetics in Medicine.

[18]  Robert W. Taylor,et al.  Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts , 2016, Journal of Inherited Metabolic Disease.

[19]  Sheila Unger,et al.  NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina , 2015, American journal of medical genetics. Part A.

[20]  A. Mégarbané,et al.  Neuroblastoma Amplified Sequence (NBAS) mutation in recurrent acute liver failure: Confirmatory report in a sibship with very early onset, osteoporosis and developmental delay. , 2015, European journal of medical genetics.

[21]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[22]  Karl R. Clauser,et al.  MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins , 2015, Nucleic Acids Res..

[23]  Thomas Meitinger,et al.  Biallelic Mutations in NBAS Cause Recurrent Acute Liver Failure with Onset in Infancy , 2015, American journal of human genetics.

[24]  H. Hakonarson,et al.  Delayed diagnosis of congenital myasthenia due to associated mitochondrial enzyme defect , 2015, Neuromuscular Disorders.

[25]  D. Jain,et al.  Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology. , 2014, Journal of hepatology.

[26]  C. Pérez-Cerdá,et al.  Functional analysis and in vitro correction of splicing FAH mutations causing tyrosinemia type I , 2014, Clinical genetics.

[27]  G. Mazariegos,et al.  Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the american association for the study of liver diseases, american society of transplantation and the north american society for pediatric gastroenterology, hepatology and nutrition , 2014, Hepatology.

[28]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[29]  Magalie S Leduc,et al.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.

[30]  J. Miller,et al.  Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.

[31]  S. Gallati,et al.  Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome , 2011, BMC neurology.

[32]  Erin M. Coffee,et al.  Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance , 2010, Journal of Inherited Metabolic Disease.

[33]  M. Rivas,et al.  Nature Genetics Advance Online Publication High-throughput, Pooled Sequencing Identifies Mutations in Nubpl and Foxred1 in Human Complex I Deficiency , 2022 .

[34]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[35]  M. Takagi,et al.  Neuroblastoma amplified sequence gene is associated with a novel short stature syndrome characterised by optic nerve atrophy and Pelger–Huët anomaly , 2010, Journal of Medical Genetics.

[36]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[37]  D. Grinberg,et al.  Antisense oligonucleotide treatment for a pseudoexon‐generating mutation in the NPC1 gene causing Niemann‐Pick type C disease b , 2009, Human mutation.

[38]  E. Christensen,et al.  Highly variable clinical phenotype of carbamylphosphate synthetase 1 deficiency in one family: an effect of allelic variation in gene expression? , 2009, Clinical genetics.

[39]  A. Munnich,et al.  The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome. , 2009, Molecular genetics and metabolism.

[40]  T. Isobe,et al.  Identification of the neuroblastoma-amplified gene product as a component of the syntaxin 18 complex implicated in Golgi-to-endoplasmic reticulum retrograde transport. , 2009, Molecular biology of the cell.

[41]  Schraga Schwartz,et al.  SROOGLE: webserver for integrative, user-friendly visualization of splicing signals , 2009, Nucleic Acids Res..

[42]  M. Baumgartner,et al.  Identification of novel mutations in the SLC25A15 gene in hyperornithinemia‐hyperammonemia‐homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study , 2009, Human mutation.

[43]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[44]  Song Zhang,et al.  Serum α‐NH2‐butyric acid may predict spontaneous survival in pediatric acute liver failure , 2009, Pediatric transplantation.

[45]  A. Ribes,et al.  Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. , 2008, Molecular genetics and metabolism.

[46]  H. Willenbring,et al.  Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene , 2002, Human Genetics.

[47]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[48]  T. Saheki,et al.  Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia , 1995, Human Genetics.

[49]  D. Cox,et al.  The Wilson disease gene: spectrum of mutations and their consequences , 1995, Nature Genetics.

[50]  M. Grompe,et al.  A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. , 1994, The New England journal of medicine.

[51]  C. Wadelius,et al.  Galactosemia caused by a point mutation that activates cryptic donor splice site in the galactose-1-phosphate uridyltransferase gene. , 1993, Genomics.

[52]  M. Kabra,et al.  Molecular Diagnosis of Hereditary Fructose Intolerance: Founder Mutation in a Community from India. , 2015, JIMD reports.

[53]  Ann E. Frazier,et al.  Biochemical analyses of the electron transport chain complexes by spectrophotometry. , 2012, Methods in molecular biology.

[54]  J. Stockman.  Acute Liver Failure in Children: The First 348 Patients in the Pediatric Acute Liver Failure Study Group , 2008 .

[55]  Y. Takeshima,et al.  Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation. , 2007, The Kobe journal of medical sciences.